Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by QIAGEN N.V.
< Previous
1
2
Next >
QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results
March 13, 2023
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug
March 09, 2023
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing
March 01, 2023
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN’s tuberculosis blood test QuantiFERON-TB Gold Plus gains CE-marking under new EU IVDR framework
February 14, 2023
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups
February 07, 2023
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN Launches EZ2 Connect MDx Platform for Automated Sample Processing in Diagnostic Labs
January 17, 2023
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN N.V. to Release Results for Q4 and Full-Year Results 2022 and Hold Webcast
January 17, 2023
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN and Helix Launch Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases
January 05, 2023
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer
December 13, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance
November 21, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN Exceeds Outlook for Q3 2022 with 18% CER Sales Growth in Non-COVID Product Portfolio and Raises Full-Year 2022 Outlook
November 07, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN N.V. to Release Results for Q3 2022 and Hold Webcast
October 21, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN Adds New Assays With CE-IVD Certification for NeuMoDx Integrated PCR System
September 15, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug
September 14, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN Issues 2021 Sustainability Report
August 18, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency
August 15, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN adds new biopharma products to QIAcuity digital PCR portfolio and launches Expert Custom Assay Design Service
July 27, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN beats outlook for Q2 2022 and raises full-year 2022 outlook
July 26, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN’s Clinical Decision Support Platform QCI Surpasses Three Million NGS Patient Test Cases
July 19, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN N.V. to Release Results for Q2 2022 and Hold Webcast
July 07, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
U.S. CDC Endorses the Use of Digital PCR Technology for Wastewater Surveillance of Infectious Diseases – Including COVID-19 Outbreaks
June 01, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN’s Eco-Friendlier Products Earn Prestigious ACT Label
May 19, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
May 16, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.
May 11, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN Proposes Expansion of Supervisory Board
May 11, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN Adds HSV1/2 Herpes Assay With CE-IVD Certification for Use on NeuMoDx Integrated PCR System
May 05, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN exceeds outlook for Q1 2022, delivers strong 14% CER sales growth from non-COVID products and increases full-year outlook
April 26, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN N.V. to release results for Q1 2022 and hold Webcast
April 20, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN Reaches Milestone With 100 Million QuantiFERON Tests Used to Detect TB
March 24, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
QIAGEN Announces 20-F Annual Report Filing for 2021 Results
March 14, 2022
From
QIAGEN N.V.
Via
Business Wire
Tickers
QGEN
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.